ERBB2 and breast cancer: In sensitivity analyses, the 235 breast cancer cases included in this analysis differed from the 344 cases without tumor tissue who were otherwise eligible for inclusion with regard to year of diagnosis, tumor invasiveness and size, HER2 enrichment, menopausal status at diagnosis, and some breast cancer risk factors (Additional file 1: Supplemental Table 4).